TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Jokowi wants COVID-19 vaccine available within three months, research team says

Padjajaran University professor Kusnandi Rusmil said Jokowi had called on the research team to fast-track the potential vaccine during a private meeting held at the State Palace in Jakarta on Tuesday.

News Desk (The Jakarta Post)
Jakarta
Wed, July 22, 2020

Share This Article

Change Size

Jokowi wants COVID-19 vaccine available within three months, research team says A woman holds a small bottle labeled "Vaccine COVID-19" in this illustration photo taken on April 10. (REUTERS/Dado Ruvic/Illustration)

P

resident Joko “Jokowi” Widodo has urged Padjajaran University’s Medical School research team in Bandung, West Java to make the Sinovac COVID-19 vaccine available for widespread use within three months amid mounting concerns over the ongoing health crisis.

Padjajaran University professor Kusnandi Rusmil said Jokowi had called on the research team to fast-track the potential vaccine during a private meeting held at the State Palace in Jakarta on Tuesday.

“There was a special instruction from the President to expedite [the production] of the coronavirus vaccine within three months, if possible,” Kusnandi told the press after the meeting.

However, he said the team could not possibly fulfill Jokowi’s request, as the clinical trials for the possible vaccine entailed a string of stringent protocols that would otherwise take years to complete under normal circumstances.

“We told [the President] that three months is impossible. We need to conduct proper testing,” Kusnandi added.

He went on to say that he expected the vaccine – developed by Chinese biopharmaceutical firm Sinovac Biotech in collaboration with state-owned pharmaceutical holding company PT Bio Farma – to pass phase III clinical trials as early as next January with a total of 1,620 samples tested.

Bio Farma president director Honesti Basyir said the company had planned to distribute 40 million doses of the vaccine per year as soon as the government authorized its widespread usage.

According to the official government count, Indonesia has 89,869 confirmed COVID-19 cases with 4,320 deaths as of Tuesday. (rfa)

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.